Evidence map›Paper›PMID 29156804›Full record

ArticleOncotarget2017

HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression.

Jian Ma, Yanxin Fan, Tingting Feng, Fangjun Chen, Zhipeng Xu, Suqing Li, Qingfeng Lin, Xiaoting He, Weihong Shi, Yang Liu and 3 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Hsa_circRNA_0101125 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma via miR-143-3p/ZNF148 Axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  2. Roles of long non-coding RNAs in oesophageal cancer pathogenesis.International journal of experimental pathology · 2025
    Review
  3. Article
  4. Turkish journal of medical sciences · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Progress of HOTAIR-microRNA in hepatocellular carcinoma.Hereditary cancer in clinical practice · 2022
    Review
  9. Review
  10. Epigenetic Changes and Functions in Pneumoconiosis.Oxidative medicine and cellular longevity · 2022
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. MicroRNA-216b targetsInternational journal of biological sciences · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jian MaDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Yanxin FanJiangsu Cancer Hospital, Medical School of Nanjing University, Nanjing 210008, Jiangsu Province, China.
Tingting FengDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Fangjun ChenThe Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing 210008, Jiangsu Province, China.
Zhipeng XuDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Suqing LiDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Qingfeng LinDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Xiaoting HeDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Weihong ShiDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Yang LiuDepartment of Pharmacy, No.401 Hospital of Chinese People's Liberation Army, Qingdao 266071, Shandong Province, China.
Zhihua LiuState Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.
Bin ZhuDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Xiufeng CaoDepartment of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University, Oncology Center of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China.
Nanjing Medical University · CNNanjing University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal Squamous Cell Carcinoma (ESCC) is one of the most common malignant cancers worldwide with a high death rate worldwide. Long non-coding RNA (LncRNA) has been recently demonstrated to play a critical role in ESCC. LncRNA HOTAIR played important regulatory roles in ESCC. We highlight the molecular mechanisms by which HOTAIR could influence the expression of Hexokinase 2 (HK2) in ESCC through binding miR-125 and miR-143 directly. Taken together, this study identified a functional lncRNA HOTAIR involved with regulation of glycolysis via miRNA-125/miRNA-143-HK2 in ESCC cells. The "competitive endogenous RNA" (ceRNA) model of HOTAIR/miR-125 and miR143/HK2 interaction might serve as important targets for ESCC diagnosis and therapy.

Indexed as

ESCCHK2HOTAIRmiR-125miR-143

Identifiers

PMID29156804
PMCPMC5689694
OpenAlexW2760510507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.